Lawton, Ralph I.
Stanford, Fatima Cody
Funding for this research was provided by:
National Institute of Diabetes and Digestive and Kidney Diseases (U24DK132733)
Article History
Accepted: 1 November 2023
First Online: 3 January 2024
Compliance with Ethical Standards
:
: Dr. Fatima Cody Stanford has served as a paid consultant/advisor for Novo Nordisk, Eli Lilly, Pfizer, Boheringer Ingelheim, Currax, Gelesis, Rhythm, Calibrate, Sweetch, Vida Health, and Ilant Health.
: This article does not contain any studies with human or animal subjects performed by any of the authors.